Pacer Advisors, Inc. Biogen Inc. Transaction History

Pacer Advisors, Inc.

$39 Billion
Q2 2024

A detailed history of Pacer Advisors, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 19,066 shares of BIIB stock, worth $3.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,066

Previous 16,917 12.7%

Holding current value

$3.31 Million

Previous $3.65 Million 21.17%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $409,427 - $508,711	2,149 Added 12.7%	19,066 $4.42 Million
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $2.55 Million - $3.22 Million	-12,012 Reduced 41.52%	16,917 $3.65 Million
Q4 2023 Jan 16, 2024	BUY	$222.59 - $267.94 $2.75 Million - $3.31 Million	12,343 Added 74.42%	28,929 $7.49 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $457,459 - $516,317	1,806 Added 12.22%	16,586 $4.26 Million
Q2 2023 Jul 12, 2023	SELL	$275.25 - $318.06 $600,045 - $693,370	-2,180 Reduced 12.85%	14,780 $4.21 Million
Q1 2023 May 02, 2023	BUY	$256.56 - $292.34 $3.12 Million - $3.55 Million	12,157 Added 253.11%	16,960 $4.72 Million
Q4 2022 Feb 06, 2023	SELL	$252.44 - $306.72 $86.4 Million - $105 Million	-342,262 Reduced 98.62%	4,803 $1.33 Million
Q3 2022 Oct 18, 2022	SELL	$194.69 - $268.46 $27.4 Million - $37.7 Million	-140,561 Reduced 28.83%	347,065 $92.7 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $30.7 Million - $36.5 Million	163,478 Added 50.43%	487,626 $99.4 Million
Q1 2022 Apr 05, 2022	BUY	$193.77 - $244.14 $60.4 Million - $76.1 Million	311,731 Added 2510.52%	324,148 $68.3 Million
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $724,381 - $930,935	-3,235 Reduced 20.67%	12,417 $2.98 Million
Q3 2021 Oct 15, 2021	SELL	$282.99 - $369.05 $11.2 Million - $14.6 Million	-39,494 Reduced 71.62%	15,652 $4.43 Million
Q2 2021 Jul 21, 2021	BUY	$259.0 - $414.71 $4.7 Million - $7.53 Million	18,151 Added 49.06%	55,146 $19.1 Million
Q1 2021 Apr 05, 2021	BUY	$242.95 - $284.63 $281,822 - $330,170	1,160 Added 3.24%	36,995 $10.3 Million
Q4 2020 Jan 20, 2021	SELL	$236.26 - $355.63 $1.08 Million - $1.62 Million	-4,560 Reduced 11.29%	35,835 $8.78 Million
Q3 2020 Oct 19, 2020	SELL	$264.77 - $305.71 $543,572 - $627,622	-2,053 Reduced 4.84%	40,395 $11.5 Million
Q2 2020 Jul 29, 2020	BUY	$258.66 - $342.55 $3.89 Million - $5.15 Million	15,024 Added 54.78%	42,448 $11.4 Million
Q1 2020 Apr 23, 2020	BUY	$268.85 - $341.04 $3.55 Million - $4.51 Million	13,210 Added 92.94%	27,424 $9.39 Million
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $8.9 Million - $12.3 Million	-40,427 Reduced 73.99%	14,214 $4.22 Million
Q3 2019 Oct 10, 2019	BUY	$217.44 - $243.88 $191,347 - $214,614	880 Added 1.64%	54,641 $12.7 Million
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $2.25 Million - $2.48 Million	10,251 Added 23.56%	53,761 $12.6 Million
Q1 2019 Apr 10, 2019	BUY	$216.71 - $338.96 $7.08 Million - $11.1 Million	32,680 Added 301.75%	43,510 $10.3 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $4.88 Million - $6.18 Million	-17,519 Reduced 61.8%	10,830 $3.26 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $2.63 Million - $3.44 Million	8,950 Added 46.14%	28,349 $10 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $1.48 Million - $1.76 Million	5,729 Added 41.91%	19,399 $5.63 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $526,242 - $744,281	2,023 Added 17.37%	13,670 $3.74 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1.13 Million - $1.26 Million	3,662 Added 45.86%	11,647 $3.71 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $2.24 Million - $2.63 Million	7,985	7,985 $2.5 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Biogen Inc. Transaction History